Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE3.8300
- TODAY'S CHANGE (%)-0.1500 (-3.7688%)
- Bid / Lots3.7200/ 5
- Ask / Lots4.5000/ 10
- Open / Previous Close3.9100 / 3.9800
- Day Range
- 52 Week Range
- Volume269,914
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 1538 | 3.96 |
| 09:34 ET | 499 | 3.85 |
| 09:36 ET | 166 | 3.875 |
| 09:38 ET | 100 | 3.87 |
| 09:43 ET | 400 | 3.93 |
| 09:45 ET | 300 | 3.93 |
| 09:48 ET | 100 | 3.94 |
| 09:50 ET | 100 | 3.94 |
| 09:54 ET | 300 | 3.91 |
| 09:57 ET | 450 | 3.91 |
| 09:59 ET | 200 | 3.92 |
| 10:01 ET | 100 | 3.93 |
| 10:03 ET | 328 | 3.91 |
| 10:12 ET | 603 | 3.92 |
| 10:21 ET | 2937 | 3.9101 |
| 10:30 ET | 200 | 3.91 |
| 10:32 ET | 100 | 3.915 |
| 10:33 ET | 350 | 3.92 |
| 10:35 ET | 510 | 3.9 |
| 10:39 ET | 100 | 3.895 |
| 10:42 ET | 416 | 3.925 |
| 10:44 ET | 200 | 3.91 |
| 10:51 ET | 200 | 3.9 |
| 10:55 ET | 1435 | 3.89 |
| 10:57 ET | 28340 | 3.9242 |
| 11:00 ET | 300 | 3.94 |
| 11:02 ET | 400 | 3.95 |
| 11:04 ET | 688 | 3.97 |
| 11:06 ET | 15409 | 3.8886 |
| 11:08 ET | 400 | 3.89 |
| 11:09 ET | 100 | 3.89 |
| 11:15 ET | 300 | 3.88 |
| 11:20 ET | 100 | 3.88 |
| 11:22 ET | 750 | 3.85 |
| 11:24 ET | 1550 | 3.83 |
| 11:26 ET | 1922 | 3.82 |
| 11:27 ET | 200 | 3.82 |
| 11:29 ET | 900 | 3.82 |
| 11:33 ET | 18549 | 3.8601 |
| 11:36 ET | 500 | 3.845 |
| 11:38 ET | 950 | 3.87 |
| 11:40 ET | 300 | 3.88 |
| 11:42 ET | 300 | 3.9 |
| 11:44 ET | 400 | 3.87 |
| 11:45 ET | 250 | 3.871 |
| 11:47 ET | 100 | 3.88 |
| 11:49 ET | 100 | 3.88 |
| 11:51 ET | 300 | 3.87 |
| 11:54 ET | 100 | 3.89 |
| 11:56 ET | 100 | 3.875 |
| 11:58 ET | 200 | 3.87 |
| 12:00 ET | 300 | 3.86 |
| 12:02 ET | 200 | 3.87 |
| 12:05 ET | 100 | 3.88 |
| 12:07 ET | 100 | 3.87 |
| 12:12 ET | 28278 | 3.81 |
| 12:14 ET | 1129 | 3.83 |
| 12:16 ET | 1999 | 3.8499 |
| 12:20 ET | 3786 | 3.83 |
| 12:21 ET | 5116 | 3.8 |
| 12:23 ET | 294 | 3.8 |
| 12:25 ET | 600 | 3.8 |
| 12:27 ET | 1386 | 3.79 |
| 12:32 ET | 100 | 3.8 |
| 12:34 ET | 400 | 3.79 |
| 12:36 ET | 100 | 3.8 |
| 12:38 ET | 336 | 3.8 |
| 12:41 ET | 100 | 3.81 |
| 12:43 ET | 200 | 3.81 |
| 12:45 ET | 100 | 3.8029 |
| 12:50 ET | 100 | 3.805 |
| 12:54 ET | 698 | 3.8 |
| 12:57 ET | 600 | 3.785 |
| 12:59 ET | 1000 | 3.77 |
| 01:06 ET | 100 | 3.77 |
| 01:08 ET | 789 | 3.7899 |
| 01:10 ET | 100 | 3.8 |
| 01:12 ET | 1100 | 3.77 |
| 01:17 ET | 100 | 3.78 |
| 01:19 ET | 2231 | 3.77 |
| 01:21 ET | 2100 | 3.76 |
| 01:24 ET | 9800 | 3.7662 |
| 01:26 ET | 299 | 3.75 |
| 01:28 ET | 30732 | 3.7543 |
| 01:30 ET | 1500 | 3.7656 |
| 01:35 ET | 200 | 3.76 |
| 01:37 ET | 600 | 3.77 |
| 01:39 ET | 200 | 3.78 |
| 01:42 ET | 1235 | 3.77 |
| 01:53 ET | 901 | 3.76 |
| 01:55 ET | 100 | 3.75 |
| 01:57 ET | 200 | 3.77 |
| 02:00 ET | 200 | 3.765 |
| 02:02 ET | 200 | 3.765 |
| 02:04 ET | 2425 | 3.765 |
| 02:06 ET | 464 | 3.765 |
| 02:08 ET | 100 | 3.765 |
| 02:11 ET | 300 | 3.77 |
| 02:13 ET | 100 | 3.775 |
| 02:15 ET | 3387 | 3.785 |
| 02:20 ET | 777 | 3.7833 |
| 02:22 ET | 1722 | 3.7787 |
| 02:24 ET | 400 | 3.77 |
| 02:29 ET | 3413 | 3.7879 |
| 02:31 ET | 500 | 3.78 |
| 02:36 ET | 6195 | 3.795 |
| 02:38 ET | 100 | 3.795 |
| 02:42 ET | 300 | 3.8 |
| 02:44 ET | 900 | 3.77 |
| 02:51 ET | 200 | 3.78 |
| 02:56 ET | 952 | 3.79 |
| 02:58 ET | 199 | 3.79 |
| 03:02 ET | 500 | 3.79 |
| 03:03 ET | 300 | 3.79 |
| 03:05 ET | 1790 | 3.7981 |
| 03:07 ET | 863 | 3.8 |
| 03:09 ET | 600 | 3.79 |
| 03:12 ET | 3800 | 3.79 |
| 03:14 ET | 530 | 3.7841 |
| 03:18 ET | 600 | 3.805 |
| 03:21 ET | 300 | 3.81 |
| 03:23 ET | 100 | 3.815 |
| 03:27 ET | 100 | 3.82 |
| 03:30 ET | 100 | 3.82 |
| 03:32 ET | 100 | 3.82 |
| 03:34 ET | 466 | 3.82 |
| 03:36 ET | 100 | 3.83 |
| 03:39 ET | 1200 | 3.82 |
| 03:48 ET | 381 | 3.83 |
| 03:50 ET | 100 | 3.835 |
| 03:52 ET | 1100 | 3.83 |
| 03:54 ET | 700 | 3.83 |
| 03:56 ET | 271 | 3.825 |
| 03:57 ET | 100 | 3.825 |
| 03:59 ET | 19144 | 3.83 |
May 2, 2024
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform, from 4:30PM ET on Thursday May 02, 2024 by Dow Jones
4:30PM ET on Thursday May 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 209.1M | -0.8x | --- |
Galectin Therapeutics Inc | 207.4M | -4.3x | --- |
Omeros Corp | 210.9M | -1.3x | --- |
Atossa Therapeutics Inc | 213.0M | -7.0x | --- |
Renovaro Inc | 214.1M | -2.1x | --- |
Ovid Therapeutics Inc | 212.4M | -4.2x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Lead Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $209.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.47 |
EPS | $-4.97 |
Book Value | $5.06 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
